Another Weak Month for Healthcare and Biotech Stocks: What’s going on?,,,,Update-2….Small cap rally!
Update-2 Small cap biotech rally continues..11/15/23.. 10:30am EST......As per previous post we are now in the beginning of an SMID Rally.See our post from last week with potential trades many of which are already up 10% or more:ABOS, CRBU, CRSP, CYRX, PACB, SUPN, VCYT...XBI up 2.2% at...
Risk On for Biotech-Time To Trade the Small CAPS!…Update-2…caution?
Update-2 11/10/23...Reversal from yesterday's bad tape, back to TECH stocks and NAZ up 2%. Small caps up but lagging same for biopharma. Hologic a big winner, other SMID winners: CRSP, QDEL,SUPN, VCYT--ILMN a big loser. IBB up 0.48%. Update-1 2:15 P EST ...Something is rattling biopharma...
Healthcare Playbook: Hardly Defensive with a Covid Hangover in Biotech…Update-2…smallcaps moving!
Update-2 11/4/23...Small caps starting to show momentum after a big week with QQQ up over 6%, IWM up 7.56%, IJR up 7.45%. Seasonality of Q4 gains off to a good start. Broad market rally was sparked by lower bond yields. Even MRNA launches off bottom after disappointing earnings, big write-off....
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield etc. Update-2… After a challenging week
Update-2 10/30...10:30a EDT Rally or not? I will post tomorrow to see if rally holds from gloomy sentiment driven by MACRO. Stocks we follow that are up on opening: ABBV, LLY, MRK. SMID biotech and MEDTECH stocks are still not tradeable: DHR an TMO are red again this morning. Healthcare...
Raygent Healthcare Portfolio Focus Stocks…Update-1…ABT, MRK
Update-2 10/20 Merck (MRK) pops over 2% to $102+ on ADC deal with Daiichi Sankyo. Collaboration combines Daiichi Sankyo’s proven ADC expertise and DXd technology with Merck’s deep experience in oncology and clinical development capabilities to advance and expand the reach of ADCs for patients...